Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases
about
Structural Mechanisms and Drug Discovery Prospects of Rho GTPasesMolecular classification of gastric cancer: Towards a pathway-driven targeted therapyApproaches of targeting Rho GTPases in cancer drug discoveryRho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and diseaseRational design of small molecule inhibitors targeting the Ras GEF, SOS1.Wnt5a and Wnt11 regulate mammalian anterior-posterior axis elongationMyxoma virus oncolytic efficiency can be enhanced through chemical or genetic disruption of the actin cytoskeletonAutomated NMR fragment based screening identified a novel interface blocker to the LARG/RhoA complexA Pan-GTPase Inhibitor as a Molecular ProbeA novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivoNuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomasCellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription.Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancerTargeting Rho-GTPases in immune cell migration and inflammation.Use of synthetic isoprenoids to target protein prenylation and Rho GTPases in breast cancer invasionTargeting GTPases in Parkinson's disease: comparison to the historic path of kinase drug discovery and perspectivesProtein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays.Combined rational design and a high throughput screening platform for identifying chemical inhibitors of a Ras-activating enzymeLoss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice.RhoA and Rac1 GTPases Differentially Regulate Agonist-Receptor Mediated Reactive Oxygen Species Generation in PlateletsComposite microsphere-functionalized scaffold for the controlled release of small molecules in tissue engineering.Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factorsARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cells.Cancer cell-derived 12(S)-HETE signals via 12-HETE receptor, RHO, ROCK and MLC2 to induce lymph endothelial barrier breaching.Cell type-specific signaling function of RhoA GTPase: lessons from mouse gene targeting.Diagnosis and Therapy of Atrial Fibrillation: The Past, The Present and The Future.Annexin A1 restores Aβ1-42 -induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway.Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer.Rho GTPases in erythroid maturation.Direct Modulation of Small GTPase Activity and Function.Molecular perturbation strategies to examine spatiotemporal features of Rho GEF and Rho GTPase activity in living cells.The lens actin filament cytoskeleton: Diverse structures for complex functions.Rho GTPases: Anti- or pro-neoplastic targets?Bud detachment in hydra requires activation of fibroblast growth factor receptor and a Rho-ROCK-myosin II signaling pathway to ensure formation of a basal constriction.Genomic landscape of gastric cancer: molecular classification and potential targets.Rho GTPases, their post-translational modifications, disease-associated mutations and pharmacological inhibitors.Rho GTPases and cancer.Rho GTPases as therapeutic targets in cancer (Review).Molecular pathways: targeting the kinase effectors of RHO-family GTPases.Stress responses. Mutations in a translation initiation factor identify the target of a memory-enhancing compound.
P2860
Q26745863-6AB37360-8210-4A38-BD50-59BDF3886893Q26798420-F9FBCF7A-0962-45E8-8DEC-89E2E49678D6Q26851300-C2413C16-79F7-4E3C-AA3E-B818C8478074Q26853181-2FF7F5FA-D209-4BA7-B5F8-E81D4762995CQ27318713-2E3B0EA3-6D7A-4050-827F-66EE4DD2F34AQ28510199-77294512-B087-47CE-8C91-DB57A0A25879Q28538172-E599BDA3-9D2B-44C3-8EF6-0F975FE7E48AQ28539542-2C9FF760-B444-4C0F-BC55-CCF84D8F0DF3Q28547072-B997F789-A146-48A8-B7E2-E27E9F952EE6Q30665888-FC553355-C991-4B5A-83B8-8A31A40459D2Q33787201-52D80137-A9E2-46AB-846B-F6B81BACDAB3Q33840143-2DD32455-3390-43E6-8493-AE800BF07D7BQ34295621-EA72615D-873F-4546-B948-ABFDE6BD5514Q34803380-DEB7760A-7B5B-4284-8916-966EA3070802Q35108286-870EFA46-F9EF-45C5-9B8A-82CF71F3391EQ35187475-34217278-15D3-414E-BC94-FECC101237B6Q35397776-D099EC0D-DBB7-4544-B962-D3DFA4678558Q35590750-B420BBEE-683F-4D88-BC11-0EAE7E4B1005Q35648144-C2FABDCE-6E45-4A38-8A1C-9C27DA0E0689Q36146913-9FB47717-D5C9-4614-8497-9D9D60CFD5D8Q36613949-08480217-8001-4978-8F7D-9D2D51500C1FQ36637356-48F1BF32-92EA-44CA-A9F0-D758FA3808F9Q36871396-B570678C-D84C-42A4-8219-E38204ABD8D3Q37151095-C8914A8C-9FEE-4251-81AC-5E4836A35322Q37404956-E55C5B6B-1BD3-48B5-A0DA-2D285F16DEC7Q37468899-917ECEA6-B413-4E45-8EAB-A7478DF38AECQ37591999-E0933EE2-B052-4E45-938B-D62F5EFA7039Q37697178-95E28808-6FC4-4C55-ADD5-23F84B517253Q38184866-29AA15B5-0B4A-484C-B0E5-2580B7725286Q38608107-2E8CDB0E-25E6-4BA6-A2EB-D86880E63850Q38682208-4F96DE65-CD52-40A4-BA47-77B423A1F9EEQ38772098-5E9352CC-ACEC-4B76-8B7D-A540EE4261CBQ38780866-992FC269-C2BF-48D5-B29D-9AC3DA265F67Q38836061-ED417343-4B65-40E2-9C8F-F1FCFB4D2F01Q38837669-236151CE-F0BC-4CC2-BDA9-9A0CDB796CBFQ38933808-F56EACC0-64A0-4FDE-BC24-E61905F85129Q39283279-CAA71852-D702-4029-97D9-7DAE8064E3A8Q41387997-35453FB7-D6D5-4843-8580-D1AA1C1C4AC9Q42099107-B917BB26-B7A4-44FC-9037-B8C377F0B986Q42552086-0867FB67-63CC-49F3-95AB-B7AC2C74BFF9
P2860
Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases
@ast
Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases
@en
Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases
@nl
type
label
Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases
@ast
Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases
@en
Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases
@nl
prefLabel
Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases
@ast
Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases
@en
Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases
@nl
P2093
P2860
P3181
P1476
Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases
@en
P2093
Chris R Evelyn
Fillipo Marchioni
Moran Jerabek-Willemsen
Nisha Sipes
Stefan Duhr
William Seibel
P2860
P304
P3181
P356
10.1016/J.CHEMBIOL.2012.05.009
P407
P577
2012-06-01T00:00:00Z